AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance
Go back to AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance| AngioDynamics, Inc. (NASDAQ: ANGO) | Delayed: 12.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.39 | 52 Week High | $17.64 | |||
| Open | $12.39 | 52 Week Low | $9.71 | |||
| Day High | $12.39 | P/E | N/A | |||
| Day Low | $12.39 | EPS | $-0.07 | |||
| Volume | 2 | |||||
